Skip to Content

Logo 660 (Ropinirole Hydrochloride Extended-Release 8 mg)

Pill with imprint Logo 660 is Red, Elliptical / Oval and has been identified as Ropinirole Hydrochloride Extended-Release 8 mg. It is supplied by Actavis Elizabeth LLC.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 660

Ropinirole hydrochloride extended-release 8 mg Logo 660
Ropinirole hydrochloride extended-release 8 mg Logo 660
Ropinirole hydrochloride extended-release 8 mg Logo 660

Ropinirole Hydrochloride Extended-Release

Imprint
Logo 660
Strength
8 mg
Color
Red
Size
16.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Elizabeth LLC
Inactive Ingredients
silicon dioxide, croscarmellose sodium, castor oil, hypromelloses, lactose monohydrate, magnesium stearate, maltodextrin, titanium dioxide, ferric oxide red, polyethylene glycol, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00228-3660 Actavis Pharma, Inc.
42291-0716 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.